dc.contributor.author | Ozekmekci, Sibel | |
dc.contributor.author | Erginoz, Ethem | |
dc.contributor.author | Delil, Sakir | |
dc.contributor.author | Apaydin, Hulya | |
dc.contributor.author | Benbir, Gulcin | |
dc.date.accessioned | 2021-03-03T20:57:23Z | |
dc.date.available | 2021-03-03T20:57:23Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | Benbir G., Ozekmekci S., Apaydin H., Delil S., Erginoz E., "A hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy", CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.108, sa.8, ss.726-732, 2006 | |
dc.identifier.issn | 0303-8467 | |
dc.identifier.other | av_5cac873b-4b3a-489b-af41-6962cb7c73ff | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/64956 | |
dc.identifier.uri | https://doi.org/10.1016/j.clineuro.2006.02.002 | |
dc.description.abstract | Objectives: Although levodopa (LD) is the gold standard therapy for symptomatic treatment of Parkinson's disease (PD), the chronic use of LD leads to the development of motor complications in almost all patients. | |
dc.language.iso | eng | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Nöroloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | CERRAHİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | A hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy | |
dc.type | Makale | |
dc.relation.journal | CLINICAL NEUROLOGY AND NEUROSURGERY | |
dc.contributor.department | , , | |
dc.identifier.volume | 108 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 726 | |
dc.identifier.endpage | 732 | |
dc.contributor.firstauthorID | 180485 | |